| Subject: | CDC Updates Clinicians About Limited Rabies Vaccine Supply |
| Category: | Centers for Disease Control and Prevention (CDC)
|
| Published: | Tue, 26 Aug 2008 - 06:00 am |
| The Centers for Disease Control and Prevention (CDC) has been notified by Novartis, maker of RabAvert (Rabies Vaccine), that the supply of human rabies vaccine is being used at a higher rate than expected, which may affect the near-term availability of vaccine for rabies post-exposure prophylaxis (PEP). This development follows the August 14 news release by Sanofi Pasteur, which announced the unavailability of the IMOVAX ® vaccine until late September-early October. Because of limited... The full article is available to StayAlert subscribers. Click here for a free trial subscription. |
|
RESOURCES:
Customizable Documents and Tools:
External Links:
Bibliography:
|
|
With over 20 years experience in regulatory compliance, MCN Healthcare brings you the most comprehensive regulatory compliance tool available. StayAlert! is the only comprehensive e-mail notification service available that not only notifies you of the changes in major federal regulations, but also provides the policies, procedures, tools and best practices to help you meet the changing regulation. StayAlert! actively monitors TJC (JCAHO), CDC, CMS, DHHS, FDA, OSHA, OIG and many others so you don't have to. Other vendors have components of legislated requirements available online or on CD-ROM. However there is no other product that marries regulatory agency mandates with implementation tools, making the latest compliance information immediately available online. No other product provides an interpretative analysis, followed by a practical application tool, therefore providing users with an immediate solution to compliance problems. StayAlert! includes operational components for healthcare organizations, allowing complete facility compliance with mandated requirements, online. |
|
